{
  "abstract": "Tranexamic acid (TXA) is an antifibrinolytic agent which inhibits the activation of plasminogen to plasmin. 1 Plasmin is a fibrinolytic which causes clot breakdown and, therefore, preventing activation of plasmin prevents clot breakdown. TXA is a synthetic analogue of the amino acid lysine.",
  "authors": [
    {
      "affiliations": [
        "Paediatric Emergency Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"
      ],
      "name": "James Baker"
    },
    {
      "affiliations": [
        "Emergency Department, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"
      ],
      "name": "Brendan Fletcher"
    }
  ],
  "title": "Use of tranexamic acid in children with major haemorrhage",
  "uid": "e312d268-95c1-56dc-8298-f7d8f507c2d5"
}